SS
Susanta Samajdar
Aurigene Discovery Technologies (India), Jubilant Biosys, Indian Association for the Cultivation of Science, University of Calcutta, Syngene International (India)
0000-0002-3508-4801
Employment
-
Aurigene Discovery Technologies (India)2012 - Present
-
Jubilant Biosys Director2006 - 2012
-
Syngene International (India) Scientific Manager2002 - 2006
Education
-
Indian Association for the Cultivation of Science PhD1995 - 1999
-
University of Calcutta MSc1992 - 1994
Projects & Funding
Projects & funding information is unavailable.
Publications (38)
- A dialogue on innovation in anticancer drug discovery Save
- Correction to: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer (Nature, (2022), 601, 7893, (434-439), 10.1038/s41586-021-04246-z) Save
- Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies Save
- Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies Save
- Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance Save
- Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax Save
- Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas Save
- Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer Save
- PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras Save
- Orally Bioavailable CBP and p300 Selective Degraders for the Treatment of AR- and ER-dependent Cancers Save